WO2026126128 - PSEUDOMONAS BACTERIOPHAGE AND USES THEREOF
National phase entry is expected:
Publication Number
WO/2026/126128
Publication Date
18.06.2026
International Application No.
PCT/IB2025/062693
International Filing Date
11.12.2025
Title **
[English]
PSEUDOMONAS BACTERIOPHAGE AND USES THEREOF
[French]
BACTÉRIOPHAGE DE PSEUDOMONAS ET SES UTILISATIONS
Applicants **
BIOMX LTD.
Inventors
LIVNAT, Hila Sberro
OLSHINA, Maya
AXELROD, Tim
SLUTSKIN, Ilya Vainberg
MORDOCH, Ron
JABLONSKA, Jagoda
BUSCHSHTAB, Nufar
Priority Data
63/733,211
12.12.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3442 | |
| EPO | Filing, Examination, Granting | 26113 | |
| Japan | Filing, Examination, Granting | 2887 | |
| South Korea | Filing, Examination, Granting | 3631 | |
| USA | Filing, Examination, Granting | 10760 |
Total:
46,833
Contact Us
Abstract[English]
A composition comprising at least two different strains of isolated bacteriophages, each capable of infecting a bacteria of the species Pseudomonas aeruginosa, wherein at least a first one of said at least two different strains of isolated bacteriophages has a genomic nucleic acid sequence at least 90% identical to one of the nucleic acid sequence as set forth in SEQ ID NOs: 1-10 (such as 1-3 and 10), and wherein at least a second one of said at least two different strains of isolated bacteriophages has a genomic nucleic acid sequence at least 90% identical to one of the nucleic acid sequence as set forth in SEQ ID NOs: 11-12. Uses thereof are also disclosed.[French]
L'invention concerne une composition comprenant au moins deux souches différentes de bactériophages isolés, chacune étant apte à infecter une bactérie de l'espèce Pseudomonas aeruginosa, au moins l'une desdites au moins deux souches différentes de bactériophages isolés ayant une séquence d'acides nucléiques génomique qui est au moins 90 % identique à l'une des séquences d'acides nucléiques telles que définies dans SEQ ID No : 1-10. (tel que 1-3 et 10), et au moins une seconde desdites au moins deux souches différentes de bactériophages isolés ayant une séquence d'acides nucléiques génomique qui est au moins 90% identique à l'une des séquences d'acides nucléiques telles que présentées dans SEQ ID NO : 11-12. Des utilisations associées sont également divulguées.